<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Eloxx Pharmaceuticals Inc — News on 6ix</title>
    <link>https://6ix.com/company/eloxx-pharmaceuticals-inc</link>
    <description>Latest news and press releases for Eloxx Pharmaceuticals Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Apr 2018 22:22:43 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/eloxx-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683562cf78dffbe2df0eefd8.webp</url>
      <title>Eloxx Pharmaceuticals Inc</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc</link>
    </image>
    <item>
      <title>Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-uplisting-to-nasdaq-and-pricing-of-dollar50-million-public-offering-of-common-stock</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-uplisting-to-nasdaq-and-pricing-of-dollar50-million-public-offering-of-common-stock</guid>
      <pubDate>Wed, 25 Apr 2018 22:22:43 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-proposed-public-offering-of-common-stock</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-proposed-public-offering-of-common-stock</guid>
      <pubDate>Tue, 24 Apr 2018 20:01:44 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Announces that Two Abstracts for ELX-02 Have Been Accepted for Presentation at the 41st European Cystic Fibrosis Conference</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-that-two-abstracts-for-elx-02-have-been-accepted-for-presentation-at-the-41st-european-cystic-fibrosis-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-that-two-abstracts-for-elx-02-have-been-accepted-for-presentation-at-the-41st-european-cystic-fibrosis-conference</guid>
      <pubDate>Wed, 18 Apr 2018 15:30:14 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Announces that Two Abstracts for ELX-02 Have Been Accepted for Presentation at the 41st European Cystic Fibrosis Conference.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Reports Full Year 2017 Financial and Operating Results and Provides Business Update</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-reports-full-year-2017-financial-and-operating-results-and-provides-business-update</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-reports-full-year-2017-financial-and-operating-results-and-provides-business-update</guid>
      <pubDate>Mon, 19 Mar 2018 11:01:42 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Reports Full Year 2017 Financial and Operating Results and Provides Business Update.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Chairman and CEO Robert Ward to Participate in a Panel Discussion at the Biotech Showcase 2018 Conference</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-chairman-and-ceo-robert-ward-to-participate-in-a-panel-discussion-at-the-biotech-showcase-2018-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-chairman-and-ceo-robert-ward-to-participate-in-a-panel-discussion-at-the-biotech-showcase-2018-conference</guid>
      <pubDate>Thu, 04 Jan 2018 16:40:11 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Chairman and CEO Robert Ward to Participate in a Panel Discussion at the Biotech Showcase 2018 Conference.</description>
    </item>
    <item>
      <title>UPDATE -- Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/update-eloxx-pharmaceuticals-appoints-robert-ward-chairman-and-chief-executive-officer</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/update-eloxx-pharmaceuticals-appoints-robert-ward-chairman-and-chief-executive-officer</guid>
      <pubDate>Wed, 27 Dec 2017 13:56:40 GMT</pubDate>
      <description>UPDATE -- Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer.</description>
    </item>
    <item>
      <title>Sevion Therapeutics Announces 1-for-20 Reverse Stock Split</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-announces-1-for-20-reverse-stock-split</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-announces-1-for-20-reverse-stock-split</guid>
      <pubDate>Tue, 19 Dec 2017 14:01:42 GMT</pubDate>
      <description>Sevion Therapeutics Announces 1-for-20 Reverse Stock Split.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-first-patient-dosed-in-phase-1b-clinical-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-first-patient-dosed-in-phase-1b-clinical-trial</guid>
      <pubDate>Mon, 27 Nov 2017 13:01:17 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Announces Expansion of Intellectual Property Estate for ELX-02 with Newly Granted Patent in Europe</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-expansion-of-intellectual-property-estate-for-elx-02-with-newly-granted-patent-in-europe</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-announces-expansion-of-intellectual-property-estate-for-elx-02-with-newly-granted-patent-in-europe</guid>
      <pubDate>Mon, 16 Oct 2017 12:01:42 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Announces Expansion of Intellectual Property Estate for ELX-02 with Newly Granted Patent in Europe.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Appoints Gregory Weaver as Chief Financial Officer</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-appoints-gregory-weaver-as-chief-financial-officer</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-appoints-gregory-weaver-as-chief-financial-officer</guid>
      <pubDate>Tue, 26 Sep 2017 12:16:21 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Appoints Gregory Weaver as Chief Financial Officer.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-expands-management-team-to-support-rapid-development-of-lead-drug-candidate-elx-02-for-the-treatment-of-rare-genetic-diseases</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-expands-management-team-to-support-rapid-development-of-lead-drug-candidate-elx-02-for-the-treatment-of-rare-genetic-diseases</guid>
      <pubDate>Fri, 08 Sep 2017 12:14:43 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-secures-usdollar8-million-investment-from-lsp-increasing-total-raised-in-series-c-to-usdollar38-million</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-secures-usdollar8-million-investment-from-lsp-increasing-total-raised-in-series-c-to-usdollar38-million</guid>
      <pubDate>Wed, 02 Aug 2017 12:13:13 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million.</description>
    </item>
    <item>
      <title>Eloxx Pharmaceuticals Receives a US$6 Million Investment from KIP and DCS to Advance a Novel Disease-Modifying Therapy Targeting Genetic Diseases Including Cystic Fibrosis</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-receives-a-usdollar6-million-investment-from-kip-and-dcs-to-advance-a-novel-disease-modifying-therapy-targeting-genetic-diseases-including-cystic-fibrosis</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/eloxx-pharmaceuticals-receives-a-usdollar6-million-investment-from-kip-and-dcs-to-advance-a-novel-disease-modifying-therapy-targeting-genetic-diseases-including-cystic-fibrosis</guid>
      <pubDate>Mon, 26 Jun 2017 13:12:43 GMT</pubDate>
      <description>Eloxx Pharmaceuticals Receives a US$6 Million Investment from KIP and DCS to Advance a Novel Disease-Modifying Therapy Targeting Genetic Diseases Including Cystic Fibrosis.</description>
    </item>
    <item>
      <title>Sevion Therapeutics Inc. and Eloxx Pharmaceuticals Ltd Announce the Entering into of an Acquisition Transaction</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-inc-and-eloxx-pharmaceuticals-ltd-announce-the-entering-into-of-an-acquisition-transaction</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-inc-and-eloxx-pharmaceuticals-ltd-announce-the-entering-into-of-an-acquisition-transaction</guid>
      <pubDate>Fri, 02 Jun 2017 13:10:12 GMT</pubDate>
      <description>Sevion Therapeutics Inc. and Eloxx Pharmaceuticals Ltd Announce the Entering into of an Acquisition Transaction.</description>
    </item>
    <item>
      <title>Harlan Waksal, M.D. resigns as Chairman of the Board of Sevion Therapeutics</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/harlan-waksal-md-resigns-as-chairman-of-the-board-of-sevion-therapeutics</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/harlan-waksal-md-resigns-as-chairman-of-the-board-of-sevion-therapeutics</guid>
      <pubDate>Fri, 11 Mar 2016 03:15:10 GMT</pubDate>
      <description>Harlan Waksal, M.D. resigns as Chairman of the Board of Sevion Therapeutics.</description>
    </item>
    <item>
      <title>Sevion Therapeutics Reports First Quarter 2016 Financial Results</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-reports-first-quarter-2016-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-reports-first-quarter-2016-financial-results</guid>
      <pubDate>Tue, 17 Nov 2015 22:11:35 GMT</pubDate>
      <description>Sevion Therapeutics Reports First Quarter 2016 Financial Results.</description>
    </item>
    <item>
      <title>Sevion Therapeutics Presents Cow Antibody Platform at Protein Discovery Summit</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-presents-cow-antibody-platform-at-protein-discovery-summit</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-presents-cow-antibody-platform-at-protein-discovery-summit</guid>
      <pubDate>Wed, 21 Oct 2015 10:11:01 GMT</pubDate>
      <description>Sevion Therapeutics Presents Cow Antibody Platform at Protein Discovery Summit.</description>
    </item>
    <item>
      <title>Sevion Therapeutics Reports Fiscal Year 2015 Financial Results</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-reports-fiscal-year-2015-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-reports-fiscal-year-2015-financial-results</guid>
      <pubDate>Wed, 14 Oct 2015 21:57:03 GMT</pubDate>
      <description>Sevion Therapeutics Reports Fiscal Year 2015 Financial Results.</description>
    </item>
    <item>
      <title>Sevion Therapeutics Presents Antibody Discovery Platform at International Conference</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-presents-antibody-discovery-platform-at-international-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-presents-antibody-discovery-platform-at-international-conference</guid>
      <pubDate>Tue, 22 Sep 2015 10:06:59 GMT</pubDate>
      <description>Sevion Therapeutics Presents Antibody Discovery Platform at International Conference.</description>
    </item>
    <item>
      <title>Sevion Therapeutics, Inc. Announces Close of Private Placement Financing for Gross Proceeds of Approximately $6.55 Million</title>
      <link>https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-inc-announces-close-of-private-placement-financing-for-gross-proceeds-of-approximately-dollar655-million</link>
      <guid isPermaLink="true">https://6ix.com/company/eloxx-pharmaceuticals-inc/news/sevion-therapeutics-inc-announces-close-of-private-placement-financing-for-gross-proceeds-of-approximately-dollar655-million</guid>
      <pubDate>Mon, 03 Aug 2015 10:35:00 GMT</pubDate>
      <description>Sevion Therapeutics, Inc. Announces Close of Private Placement Financing for Gross Proceeds of Approximately $6.55 Million.</description>
    </item>
  </channel>
</rss>